Page last updated: 2024-10-18

imidazole and von Willebrand Diseases

imidazole has been researched along with von Willebrand Diseases in 2 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

von Willebrand Diseases: Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cinotti, S1
Paladino, E1
Morfini, M1
Verbruggen, B1
Giles, A1
Samis, J1
Verbeek, K1
Mensink, E1
Novákovà, I1

Other Studies

2 other studies available for imidazole and von Willebrand Diseases

ArticleYear
Accuracy of FVIII: C assay by one-stage method can be improved using hemophilic plasma as diluent.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:4

    Topics: Blood Coagulation; Blood Coagulation Tests; Buffers; Calibration; Chemistry, Clinical; Factor VII; H

2006
The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
    Thrombosis and haemostasis, 2001, Volume: 86, Issue:6

    Topics: Blood Coagulation Tests; Buffers; Factor Va; Factor VIII; False Positive Reactions; Hemophilia A; Hu

2001